Assignee

Dicerna Pharmaceuticals, Inc.

Patents = 98

Trademarks = 7

Forward Citations = 349

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

42 inventors (with patents filed for the assignee):

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of RNA interference (RNAi)-based therapeutics. We are committed to leveraging our proprietary GalXC RNAi technology platform to develop innovative medicines for patients with rare diseases, liver diseases, cardiovascular diseases, and more.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com